Unknown

Dataset Information

0

Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial.


ABSTRACT: BACKGROUND:High-permeability pulmonary edema is a hallmark of acute respiratory distress syndrome (ARDS) and is frequently accompanied by impaired alveolar fluid clearance (AFC). AP301 enhances AFC by activating epithelial sodium channels (ENaCs) on alveolar epithelial cells, and we investigated its effect on extravascular lung water index (EVLWI) in mechanically ventilated patients with ARDS. METHODS:Forty adult mechanically ventilated patients with ARDS were included in a randomized, double-blind, placebo-controlled trial for proof of concept. Patients were treated with inhaled AP301 (n?=?20) or placebo (0.9% NaCl; n?=?20) twice daily for 7 days. EVLWI was measured by thermodilution (PiCCO®), and treatment groups were compared using the nonparametric Mann-Whitney U test. RESULTS:AP301 inhalation was well tolerated. No differences in mean baseline-adjusted change in EVLWI from screening to day 7 were found between the AP301 and placebo group (p?=?0.196). There was no difference in the PaO2/FiO2 ratio, ventilation pressures, Murray lung injury score, or 28-day mortality between the treatment groups. An exploratory subgroup analysis according to severity of illness showed reductions in EVLWI (p?=?0.04) and ventilation pressures (p?

SUBMITTER: Krenn K 

PROVIDER: S-EPMC5531100 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial.

Krenn Katharina K   Lucas Rudolf R   Croizé Adrien A   Boehme Stefan S   Klein Klaus Ulrich KU   Hermann Robert R   Markstaller Klaus K   Ullrich Roman R  

Critical care (London, England) 20170727 1


<h4>Background</h4>High-permeability pulmonary edema is a hallmark of acute respiratory distress syndrome (ARDS) and is frequently accompanied by impaired alveolar fluid clearance (AFC). AP301 enhances AFC by activating epithelial sodium channels (ENaCs) on alveolar epithelial cells, and we investigated its effect on extravascular lung water index (EVLWI) in mechanically ventilated patients with ARDS.<h4>Methods</h4>Forty adult mechanically ventilated patients with ARDS were included in a random  ...[more]

Similar Datasets

| S-EPMC5809252 | biostudies-literature
| S-EPMC7063938 | biostudies-literature
| S-EPMC6336323 | biostudies-literature
| S-EPMC4828087 | biostudies-other
| S-EPMC5630225 | biostudies-literature
| S-EPMC7894343 | biostudies-literature
| S-EPMC7871139 | biostudies-literature
| S-EPMC8847100 | biostudies-literature
| S-EPMC10725003 | biostudies-literature